News Release

View printer-friendly version
<< Back

DURECT Corporation Presenting at the UBS Global Life Sciences Conference

CUPERTINO, Calif., Sept. 21 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it will present at the UBS Global Life Sciences Conference. The conference is taking place September 25-28th at The Grand Hyatt Hotel in New York City, New York. Dr. James E. Brown, President and Chief Executive Officer, will be presenting at the conference on Wednesday, September 27th at 4:30 p.m. Eastern Standard Time (1:30 p.m. Pacific Standard Time).

(Logo: )

A live audio webcast of the presentation will be available by accessing DURECT's homepage at and clicking "Investor Relations."

About DURECT Corporation

DURECT Corporation is an emerging specialty pharmaceutical company focused on the development of pharmaceutical systems based on its proprietary drug delivery platform technologies. The company is developing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time to treat chronic and episodic diseases and conditions.

CONTACT: Schond L. Greenway, Vice President, Investor Relations and Strategic Planning of DURECT Corporation, +1-408-777-1417
Photo: NewsCom:
AP Archive:
PRN Photo Desk,
Web site: